vs
AdvanSix Inc.（ASIX）与MARCUS CORP（MCS）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是MARCUS CORP的1.9倍（$359.9M vs $193.5M），AdvanSix Inc.同比增速更快（9.4% vs 2.8%），AdvanSix Inc.自由现金流更多（$36.1M vs $26.4M），过去两年MARCUS CORP的营收复合增速更高（18.2% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
ASIX vs MCS — 直观对比
营收规模更大
ASIX
是对方的1.9倍
$193.5M
营收增速更快
ASIX
高出6.6%
2.8%
自由现金流更多
ASIX
多$9.7M
$26.4M
两年增速更快
MCS
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $193.5M |
| 净利润 | $-2.8M | — |
| 毛利率 | 7.6% | — |
| 营业利润率 | -0.7% | 0.9% |
| 净利率 | -0.8% | — |
| 营收同比 | 9.4% | 2.8% |
| 净利润同比 | -892.9% | — |
| 每股收益（稀释后） | $-0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXMCS
| Q4 25 | $359.9M | $193.5M | ||
| Q3 25 | $374.5M | $210.2M | ||
| Q2 25 | $410.0M | $206.0M | ||
| Q1 25 | $377.8M | $148.8M | ||
| Q4 24 | $329.1M | $188.3M | ||
| Q3 24 | $398.2M | $232.7M | ||
| Q2 24 | $453.5M | $176.0M | ||
| Q1 24 | $336.8M | $138.5M |
净利润ASIXMCS
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $16.2M | ||
| Q2 25 | $31.4M | $7.3M | ||
| Q1 25 | $23.3M | $-16.8M | ||
| Q4 24 | $352.0K | $986.0K | ||
| Q3 24 | $22.3M | $23.3M | ||
| Q2 24 | $38.9M | $-20.2M | ||
| Q1 24 | $-17.4M | $-11.9M |
毛利率ASIXMCS
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
营业利润率ASIXMCS
| Q4 25 | -0.7% | 0.9% | ||
| Q3 25 | -0.9% | 10.8% | ||
| Q2 25 | 7.7% | 6.3% | ||
| Q1 25 | 7.7% | -13.7% | ||
| Q4 24 | -3.9% | -1.2% | ||
| Q3 24 | 7.5% | 14.1% | ||
| Q2 24 | 11.5% | 1.3% | ||
| Q1 24 | -7.0% | -12.0% |
净利率ASIXMCS
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | 7.7% | ||
| Q2 25 | 7.7% | 3.6% | ||
| Q1 25 | 6.2% | -11.3% | ||
| Q4 24 | 0.1% | 0.5% | ||
| Q3 24 | 5.6% | 10.0% | ||
| Q2 24 | 8.6% | -11.5% | ||
| Q1 24 | -5.2% | -8.6% |
每股收益（稀释后）ASIXMCS
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.43 | — | ||
| Q1 24 | $-0.65 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $23.4M |
| 总债务越低越好 | — | $159.0M |
| 股东权益账面价值 | $815.2M | $457.4M |
| 总资产 | $1.7B | $1.0B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资ASIXMCS
| Q4 25 | $19.8M | $23.4M | ||
| Q3 25 | $23.7M | $7.4M | ||
| Q2 25 | $18.4M | $14.9M | ||
| Q1 25 | $8.3M | $11.9M | ||
| Q4 24 | $19.6M | $40.8M | ||
| Q3 24 | $17.3M | $28.4M | ||
| Q2 24 | $12.1M | $32.8M | ||
| Q1 24 | $20.6M | $17.3M |
总债务ASIXMCS
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $162.0M | ||
| Q2 25 | — | $179.9M | ||
| Q1 25 | — | $198.9M | ||
| Q4 24 | — | $159.1M | ||
| Q3 24 | — | $173.1M | ||
| Q2 24 | — | $175.7M | ||
| Q1 24 | — | $169.8M |
股东权益ASIXMCS
| Q4 25 | $815.2M | $457.4M | ||
| Q3 25 | $818.2M | $454.3M | ||
| Q2 25 | $823.7M | $448.4M | ||
| Q1 25 | $794.4M | $441.8M | ||
| Q4 24 | $774.6M | $464.9M | ||
| Q3 24 | $766.4M | $462.3M | ||
| Q2 24 | $746.6M | $449.4M | ||
| Q1 24 | $713.2M | $459.3M |
总资产ASIXMCS
| Q4 25 | $1.7B | $1.0B | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.6B | $1.0B | ||
| Q1 25 | $1.6B | $1.0B | ||
| Q4 24 | $1.6B | $1.0B | ||
| Q3 24 | $1.5B | $1.0B | ||
| Q2 24 | $1.5B | $1.1B | ||
| Q1 24 | $1.5B | $1.0B |
负债/权益比ASIXMCS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | — | 0.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $26.4M |
| 自由现金流率自由现金流/营收 | 10.0% | 13.6% |
| 资本支出强度资本支出/营收 | 7.7% | 11.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | $989.0K |
8季度趋势，按日历期对齐
经营现金流ASIXMCS
| Q4 25 | $63.7M | $48.8M | ||
| Q3 25 | $26.6M | $39.1M | ||
| Q2 25 | $21.1M | $31.6M | ||
| Q1 25 | $11.4M | $-35.3M | ||
| Q4 24 | $64.2M | $52.6M | ||
| Q3 24 | $57.3M | $30.5M | ||
| Q2 24 | $50.2M | $36.0M | ||
| Q1 24 | $-36.2M | $-15.1M |
自由现金流ASIXMCS
| Q4 25 | $36.1M | $26.4M | ||
| Q3 25 | $66.0K | $18.2M | ||
| Q2 25 | $-7.2M | $14.7M | ||
| Q1 25 | $-22.6M | $-58.3M | ||
| Q4 24 | $29.8M | $27.1M | ||
| Q3 24 | $26.8M | $12.0M | ||
| Q2 24 | $16.7M | $16.1M | ||
| Q1 24 | $-71.6M | $-30.5M |
自由现金流率ASIXMCS
| Q4 25 | 10.0% | 13.6% | ||
| Q3 25 | 0.0% | 8.7% | ||
| Q2 25 | -1.7% | 7.1% | ||
| Q1 25 | -6.0% | -39.2% | ||
| Q4 24 | 9.1% | 14.4% | ||
| Q3 24 | 6.7% | 5.2% | ||
| Q2 24 | 3.7% | 9.2% | ||
| Q1 24 | -21.3% | -22.0% |
资本支出强度ASIXMCS
| Q4 25 | 7.7% | 11.6% | ||
| Q3 25 | 7.1% | 9.9% | ||
| Q2 25 | 6.9% | 8.2% | ||
| Q1 25 | 9.0% | 15.5% | ||
| Q4 24 | 10.4% | 13.5% | ||
| Q3 24 | 7.7% | 7.9% | ||
| Q2 24 | 7.4% | 11.3% | ||
| Q1 24 | 10.5% | 11.1% |
现金转化率ASIXMCS
| Q4 25 | — | — | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | 0.67× | 4.32× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | 53.31× | ||
| Q3 24 | 2.57× | 1.31× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
